IP Verse

Crystalline Forms Of Trisodium Supramolecular Complex Comprising Valsartan And Ahu-377 And Methods Thereof - EP3229799B1

PatentPatent Analysis

EP3229799

CRYSTAL PHARMATECH
Application Number
EP15843405A
Filing Date
Dec 8, 2015
Status
Revoked
Dec 9, 2024
Grant Date
Oct 17, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3231805B1
EP3071554B1

Bibliography

The patent EP3229799B1 was granted to Crystal Pharmatech on Oct 17, 2018 following the initial filing on Dec 8, 2015 under the application number EP15843405A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

D YOUNGJul 17, 2019 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents